adenosine has been researched along with Malignant Melanoma in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (10.61) | 18.7374 |
| 1990's | 5 (7.58) | 18.2507 |
| 2000's | 9 (13.64) | 29.6817 |
| 2010's | 24 (36.36) | 24.3611 |
| 2020's | 21 (31.82) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Fan, N; Song, Y; Sun, Y; Wang, S; Wang, Y; Yan, L | 1 |
| Alix, E; Bertheau, C; Callet-Bauchu, E; Cros-Perrial, E; Devouassoux-Shisheboran, M; Dumontet, C; Harou, O; Jordheim, LP | 1 |
| Ascierto, PA; Azzaro, R; Capone, M; Del Gaudio, P; Madonna, G; Monti, MC; Morello, S; Morretta, E; Simeone, E; Sorrentino, A; Turiello, R | 1 |
| Banuelos, J; Becker, A; Chen, A; DiRenzo, D; Ginn, E; Kalisiak, J; Kimura, N; Narasappa, N; Paprcka, SL; Park, TW; Piovesan, D; Powers, JP; Purandare, B; Schindler, U; Sivick, KE; Tan, JBL; Udyavar, AR; Walters, MJ; Yin, F; Young, SW; Zhang, K | 1 |
| Liu, T; Ning, H; Piao, C; Zhang, X; Zhang, Z | 1 |
| Bu, WB; Chen, H; Cheng, XF; Gan, L; Kong, YQ; Li, R; Liu, JQ; Miao, QJ; Shi, HZ; Sun, JF; Tian, CC; Wang, Y; Xiong, JS; Zhang, CC; Zhang, EJ; Zhang, Y | 1 |
| Chen, H; Cheng, J; Du, J; Fu, J; He, T; Zhang, L; Zhang, W | 1 |
| Vellapandian, C; Yerragopu, AK | 1 |
| Chen, J; Chen, R; Garza, LA; Hu, Z; Kang, S; Liao, W; Miao, Y; Sweren, E; Wang, G; Wang, J; Zeng, D | 1 |
| Fu, J; Li, T; Liu, S; Wang, K; Wei, C; Yang, L; Zhou, B | 1 |
| Cabral, FL; Cardoso, AA; Dal Piva, CH; Ebone, RS; Gomes, CO; Gutknecht da Silva, JL; Leal, DBR; Miron, VV; Passos, DF; Schetinger, MRC | 1 |
| Belvedere, R; Giraulo, C; Hölzel, M; Landsberg, J; Leonardelli, S; Morello, S; Müller, CE; Orlando, L; Rolshoven, G; Turiello, R | 1 |
| Chai, P; Fan, X; Ge, S; Jia, R; Sun, B; Wang, S; Xu, Y; Yang, Y; Yang, YG | 1 |
| André, F; Bastide, A; David, A; Desaubry, L; Eggermont, A; Faouzi, S; Fu, Y; Malka-Mahieu, H; Martineau, S; Mateus, C; Robert, C; Routier, E; Roy, S; Scoazec, JY; Shen, S; Sun, X; Vagner, S | 1 |
| Chen, X; Dong, F; Hu, DN; Jin, S; Liu, Q; Luo, G; Reinach, PS; Wang, J; Wang, S; Xu, W; Yan, D; Zhao, Y | 1 |
| Amini, Y; Farshchi, HK; Ghaderi, A; Jaafari, MR; Khorrami, S; Mashayekhi, K; Mirzavi, F; Soleimani, A; Zamani, P | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Agrawal, K; Hui, H; Kang, Y; Li, N; Rana, TM; Tang, R; Wang, L; Yuan, J | 1 |
| Hao, L; Li, C; Liu, L; Yang, H; Yin, J; Zhong, J; Zhu, L | 1 |
| Li, F; Lin, Y; Liu, S; Lv, S; Wang, H; Wang, S | 1 |
| Chai, P; Gu, X; He, F; Jia, R; Shi, H; Wang, S; Xu, X; Yang, J; Yu, J; Zhuang, A | 1 |
| Chai, P; Fan, X; Ge, S; Jia, R; Ruan, J; Xie, M; Yu, J | 1 |
| Han, P; Liao, Y; Ni, B; Zhang, Y | 1 |
| Ahern, E; Bald, T; Barkauskas, DS; Boyle, GM; Chitsazan, A; Hölzel, M; Huntington, ND; Landsberg, J; Long, GV; Madore, J; Ngiow, SF; Rautela, J; Reinhardt, J; Schadendorf, D; Scolyer, RA; Smyth, MJ; Young, A | 1 |
| Bald, T; Glodde, N; Hölzel, M; Kolanus, W; Landsberg, J; Long, GV; Lopez-Ramos, D; Madore, J; Nettersheim, D; Ngiow, SF; Quast, T; Ramis, BB; Reinhardt, J; Ribas, A; Schadendorf, D; Schmid-Burgk, JL; Schorle, H; Scolyer, RA; Smyth, MJ; Tumeh, PC; Tüting, T; Young, A | 1 |
| Borgognoni, L; Brandani, P; Caporale, R; Di Gennaro, P; Gerlini, G; Pimpinelli, N; Sestini, S; Urso, C | 1 |
| Bar-Eli, M; Brooks, D; Calin, G; Fuentes-Mattei, E; Huang, L; Ivan, C; Jones, SJM; Kim, SJ; Lopez-Berenstein, G; Paret, H; Robertson, AG; Rodriguez-Aguayo, C; Shoshan, E; Sood, A; Velazquez-Torres, G; Xie, V | 1 |
| Avan, A; Bahreyni, A; Ferns, GA; Fuiji, H; Hassanian, SM; Khazaei, M; Rezaei, M; Ryzhikov, M | 1 |
| Felici, C; Mannavola, F; Passarelli, A; Silvestris, F; Tucci, M | 1 |
| Amigues, B; Augier, S; Bastid, J; Becquart, O; Bensussan, A; Bonnefoy, N; Chanteux, S; Courtois, R; Déjou, C; Docquier, A; Eliaou, JF; Gauthier, L; Giraudon-Paoli, M; Gourdin, N; Gros, L; Jecko, D; Michaud, HA; Morel, Y; Narni-Mancinelli, E; Paturel, C; Perrot, I; Rispaud-Blanc, H; Romagné, F; Rossi, B; Roussel, A; Vivier, E | 1 |
| Aplin, AE; Cui, YH; Deng, Y; He, C; He, YY; Hwang, S; Lu, Z; Park, G; Shah, P; Wei, J; Yang, S | 1 |
| Iannone, R; Montinaro, A; Morello, S; Pinto, A | 1 |
| Costa, VM; Diniz, C; Fresco, P; Soares, AS | 3 |
| Donovan, NC; Hoon, DSB; Irie, RF; Tanaka, R; Yu, Q | 1 |
| Bazhin, AV; Shevchenko, I; Umansky, V; Utikal, J | 1 |
| Bar-Eli, M; Birol, I; Braeuer, RR; Brooks, D; Calin, GA; Eterovic, AK; Fidler, IJ; Gershenwald, JE; Huang, L; Hwu, P; Ivan, C; Jones, SJ; Kamiya, T; Kim, SJ; Lee, HJ; Markel, G; Mobley, AK; Mosqueda, M; Nip, KM; Robertson, AG; Salameh, A; Shoshan, E; Sood, AK; Vasquez, ME; Velazquez-Torres, G; Wen, YY; Zhu, K | 1 |
| Ackroyd, J; Bagati, A; Berman, AE; Bianchi-Smiraglia, A; Bshara, W; Fink, EE; Foley, CE; Marvin, EK; Moparthy, S; Morozevich, GE; Nikiforov, MA; Shewach, DS; Wawrzyniak, JA | 1 |
| Alexander, MP; Chabanet, TB; Clancy-Thompson, E; Croteau, W; Huang, YH; Mullins, DW; Perekslis, TJ; Turk, MJ | 1 |
| Bosserhoff, AK; Dietrich, P | 1 |
| Carrega, P; Chillemi, A; Ferlazzo, G; Horenstein, AL; Malavasi, F; Mingari, MC; Morandi, B; Morandi, F; Moretta, L; Pistoia, V; Quarona, V; Zaccarello, G | 1 |
| Rodríguez-López, JN; Sánchez-del-Campo, L | 1 |
| Andreu-Pérez, P; Avila, MA; Cortés, J; Gil, R; Grueso, J; Hernandez-Losa, J; Moliné, T; Pujol, A; Recio, JA | 1 |
| Gorelik, E; Jackson, EK; Su, Y | 1 |
| Adcock, IM; Arra, C; Forte, G; Luciano, A; Montinaro, A; Morello, S; Palma, G; Pinto, A; Sorrentino, R | 1 |
| Baraldi, PG; Borea, PA; Gessi, S; Klotz, KN; Leung, E; Merighi, S; Milani, D; Mirandola, P; Varani, K | 1 |
| Ardon, E; Bar-Yehuda, S; Barer, F; Fishman, P; Madi, L; Ochaion, A | 1 |
| Benini, A; Borea, PA; Gessi, S; Leung, E; Maclennan, S; Merighi, S; Mirandola, P; Varani, K | 1 |
| Quan, F; Quan, W; Ramirez, M; Taylor, C; Vinogradov, M; Walker, P | 1 |
| Baraldi, PG; Benini, A; Borea, PA; Gessi, S; Leung, E; MacLennan, S; Merighi, S; Mirandola, P; Varani, K | 1 |
| Abrams, S; Apasov, S; Caldwell, S; Chen, JF; Gorelik, E; Huang, X; Jackson, EK; Liu, K; Lukashev, D; Ohta, A; Prasad, SJ; Ronchese, F; Sitkovsky, M; Smith, P; Wong, MK | 1 |
| Gorelik, E; Huang, X; Jackson, EK; Lokshin, A; Mandic, M; Raskovalova, T; Su, Y; Zarour, HM | 1 |
| Hayward, IP; Parsons, PG | 1 |
| Carson, DA; Kamatani, N; Nelson-Rees, WA | 1 |
| Hadfield, AF; Lazo, JS; Lee, MH; Li, CD; Maniglia, CA; Sartorelli, AC | 1 |
| Bynum, JW | 1 |
| Bregman, MD; Hadley, ME; Hruby, VJ; Sawyer, TK | 1 |
| Coomber, DW; Gero, AM; Wood, AM | 1 |
| Coomber, DW; Gero, AM; O'Sullivan, WJ | 1 |
| Itoh, K; Mizugaki, M; Shiono, T; Takahashi, R; Tamai, M | 1 |
| Bar-Yehuda, S; Barer, F; Del Valle, L; Fishman, P; Khalili, K; Madi, L | 1 |
| Dollinger, MR; Krakoff, IH | 1 |
| Gero, AM; Kerr, EA | 1 |
| Jurewicz, TJ; Liteplo, RG | 1 |
| Nozue, AT; Ono, S | 1 |
6 review(s) available for adenosine and Malignant Melanoma
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Physio-pathological effects of m6A modification and its potential contribution to melanoma.
Topics: Adenosine; Gene Expression; Humans; Melanoma; Methylation; Methyltransferases; Mutation; Oxidoreductases, N-Demethylating; Proto-Oncogene Proteins B-raf; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA, Messenger; Skin Neoplasms | 2021 |
The potential role of adenosine signaling in the pathogenesis of melanoma.
Topics: 5'-Nucleotidase; Adenosine; Apyrase; GPI-Linked Proteins; Humans; Melanoma; Signal Transduction | 2018 |
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
Topics: 5'-Nucleotidase; Adenosine; Apyrase; Biomarkers, Tumor; GPI-Linked Proteins; Humans; Immune Tolerance; Immunosuppression Therapy; Immunotherapy; Melanoma; Receptors, Purinergic P1; Signal Transduction; Tumor Microenvironment | 2019 |
Adenosine receptors as potential targets in melanoma.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Animals; Humans; Melanoma; Molecular Targeted Therapy; Receptor, Adenosine A2A; Receptor, Adenosine A3 | 2013 |
Extracellular adenosine metabolism in immune cells in melanoma.
Topics: Adenosine; Animals; Cell Line, Tumor; Humans; Melanoma; Mice; Skin Neoplasms; T-Lymphocytes | 2014 |
2 trial(s) available for adenosine and Malignant Melanoma
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Administration of high-dose continuous infusion interleukin-2 to patients age 70 or over.
Topics: Adenosine; Aged; Aged, 80 and over; Aging; Capillary Leak Syndrome; Famotidine; Hemodynamics; Humans; Immunotherapy; Infusions, Intravenous; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Time Factors; Treatment Outcome | 2005 |
59 other study(ies) available for adenosine and Malignant Melanoma
| Article | Year |
|---|---|
Itraconazole-Induced the Activation of Adenosine 5'-Monophosphate (Amp)-Activated Protein Kinase Inhibits Tumor Growth of Melanoma via Inhibiting ERK Signaling.
Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Proliferation; Humans; Itraconazole; MAP Kinase Signaling System; Melanoma | 2022 |
Variability in CD39 and CD73 protein levels in uveal melanoma patients.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Antigens, CD; Apyrase; Humans; Melanoma | 2022 |
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; B7-H1 Antigen; GPI-Linked Proteins; Humans; Lymphocytes; Melanoma; Nivolumab; Pilot Projects; Retrospective Studies | 2022 |
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity.
Topics: Adenosine; Animals; Humans; Immune Checkpoint Inhibitors; Melanoma; Mice; Programmed Cell Death 1 Receptor; Tumor Microenvironment | 2022 |
METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification.
Topics: Adenosine; Animals; beta Catenin; Core Binding Factor Alpha 1 Subunit; Melanoma; Methyltransferases; RNA, Messenger | 2022 |
N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3.
Topics: Adenosine; Amino Acid Oxidoreductases; Humans; Melanoma; RNA-Binding Proteins; RNA, Messenger | 2022 |
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
Topics: Adenocarcinoma; Adenosine; Carcinoma, Hepatocellular; COVID-19; Dipeptidyl Peptidase 4; Female; Humans; Immunity; Liver Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Pancreatic Neoplasms; Pandemics; Prospective Studies; SARS-CoV-2; Skin Neoplasms | 2023 |
Chemoimmunotherapy with doxorubicin and caffeine combination enhanced ICD induction and T-cell infiltration in B16F10 melanoma tumors.
Topics: Adenosine; Animals; Caffeine; Doxorubicin; Immunogenic Cell Death; Melanoma; Mice; T-Lymphocytes; Tumor Microenvironment | 2023 |
N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma.
Topics: Adenosine; Humans; Immunotherapy; Melanoma; Methylation; RNA; Tumor Microenvironment | 2023 |
Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues.
Topics: Adenosine; Adjuvants, Immunologic; Animals; Deoxyadenosines; Humans; Melanoma; Mice; SOX9 Transcription Factor | 2023 |
Istradefylline induces A2A/P2X7 crosstalk expression inducing pro-inflammatory signal, and reduces AKT/mTOR signaling in melanoma-bearing mice.
Topics: Adenosine; Adenosine Triphosphate; Animals; Cytokines; Melanoma; Mice; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2023 |
The CD73 is induced by TGF-β1 triggered by nutrient deprivation and highly expressed in dedifferentiated human melanoma.
Topics: 5'-Nucleotidase; Adenosine; Cell Line, Tumor; Humans; Melanoma; Nutrients; Transforming Growth Factor beta1; Tumor Microenvironment | 2023 |
m
Topics: Adenosine; Apoptosis; Cell Line, Tumor; Cell Transformation, Neoplastic; Eye Neoplasms; Gene Expression Profiling; Humans; Melanoma; Methylation; Mitochondrial Proteins; Prognosis; RNA Processing, Post-Transcriptional; RNA, Messenger | 2019 |
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells.
Topics: 5' Untranslated Regions; Adenosine; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Eukaryotic Initiation Factor-4A; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase Kinases; Melanoma; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; RNA Helicases; RNA, Messenger; Skin Neoplasms; Transcription, Genetic | 2019 |
RNA m
Topics: Adenosine; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Epigenesis, Genetic; Gene Knockdown Techniques; Humans; Melanoma; Methylation; Methyltransferases; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; RNA, Messenger; RNA, Neoplasm; Up-Regulation; Uveal Neoplasms | 2020 |
The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma.
Topics: 5'-Nucleotidase; Adenosine; Antineoplastic Agents, Immunological; Drug Delivery Systems; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Melanoma; Neoplasm Proteins; Signal Transduction; Tumor Microenvironment | 2020 |
m
Topics: Adenosine; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL10; Chemokine CXCL9; Colorectal Neoplasms; Cytokines; Humans; Immune Checkpoint Inhibitors; Immunohistochemistry; Immunotherapy; Interferon Regulatory Factor-1; Interferon-gamma; Melanoma; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Programmed Cell Death 1 Receptor; RNA-Binding Proteins; RNA-Seq; STAT1 Transcription Factor; Tumor Microenvironment | 2020 |
ALKBH5-mediated m
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Demethylation; Disease Progression; Epithelial-Mesenchymal Transition; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Uveal Neoplasms | 2021 |
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
Topics: Adenosine; Disease Progression; DNA Copy Number Variations; Gene Expression Regulation, Neoplastic; Genomics; Humans; Melanoma; Polymorphism, Single Nucleotide; Skin Neoplasms; Transcriptome; Unsupervised Machine Learning | 2021 |
m
Topics: Adenosine; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Calcium; Cell Line, Tumor; Cell Transformation, Neoplastic; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ion Channels; Melanoma; Methylation; RNA; RNA Interference; Uveal Neoplasms | 2021 |
Histone lactylation drives oncogenesis by facilitating m
Topics: Acetylation; Adenosine; Cell Line, Tumor; Cell Transformation, Neoplastic; Epigenesis, Genetic; Eye Neoplasms; Gene Expression Regulation, Neoplastic; Histones; Humans; Melanoma; Models, Biological; Oncogenes; Period Circadian Proteins; RNA-Binding Proteins; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2021 |
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.
Topics: 5'-Nucleotidase; Adenosine; Animals; Drug Therapy, Combination; GPI-Linked Proteins; Humans; Imidazoles; Lung Neoplasms; MAP Kinase Kinase 1; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Mutation; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Receptor, Adenosine A2A; Skin Neoplasms | 2017 |
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy.
Topics: 5'-Nucleotidase; Adenosine; Adoptive Transfer; Animals; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Immunotherapy; Inflammation; Melanoma; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Neoplasm Invasiveness; Prognosis; Retrospective Studies; T-Lymphocytes; Transcription Factor AP-1; Tumor Cells, Cultured | 2017 |
T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Immune Tolerance; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Neoplasm Staging; Sentinel Lymph Node; Skin Neoplasms; T-Lymphocytes, Regulatory | 2018 |
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
Topics: 3' Untranslated Regions; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Inosine; Melanoma; Mice; Mice, Nude; Microfilament Proteins; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogenes; RNA Editing; Skin Neoplasms | 2018 |
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Antibodies, Blocking; Antigens, CD; Antineoplastic Agents; Apyrase; Cell Line, Tumor; Disease Models, Animal; Gene Knock-In Techniques; Humans; Leukocytes, Mononuclear; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxaliplatin; Survival Rate; T-Lymphocytes; Tumor Microenvironment | 2019 |
m
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Demethylation; DNA Methylation; Female; Humans; Immunotherapy; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Programmed Cell Death 1 Receptor; RNA Stability; RNA, Messenger | 2019 |
Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Caspases; Cell Culture Techniques; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Humans; Melanoma; Neoplasm Metastasis; Paclitaxel | 2013 |
Tumor necrosis factor-α and apoptosis induction in melanoma cells through histone modification by 3-deazaneplanocin A.
Topics: Adenosine; Adenosylhomocysteinase; Apoptosis; Cell Line, Tumor; Histones; Humans; Melanoma; Skin Neoplasms; Tumor Necrosis Factor-alpha | 2014 |
Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Blotting, Western; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Fluorescent Antibody Technique; Humans; Melanoma; Mitosis; Paclitaxel; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2014 |
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Physiological Phenomena; Disease Progression; Drug Screening Assays, Antitumor; Humans; Inosine; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Staging; Neovascularization, Pathologic; Paclitaxel; Receptor, Adenosine A3; Tumor Cells, Cultured | 2014 |
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
Topics: Adenosine; Adenosine Deaminase; Animals; Base Sequence; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Inosine; Luciferases; Melanoma; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Neoplasm Metastasis; Neoplasm Transplantation; RNA Editing; RNA-Binding Proteins; Skin Neoplasms; Transcription Factors | 2015 |
Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity.
Topics: Adenosine; Animals; Cell Line, Tumor; Enzyme Inhibitors; Female; Guanosine Monophosphate; Humans; Immunoblotting; Immunohistochemistry; Melanoma; Melanoma, Cutaneous Malignant; Mice; Mice, SCID; Nucleotidyltransferases; Skin Neoplasms | 2015 |
Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
Topics: Adenosine; Animals; CD8-Positive T-Lymphocytes; Chemokines; Cytokines; Disease Models, Animal; Humans; Ligands; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Melanoma; Melanoma, Experimental; Mice, Knockout; Neoplasm Metastasis; Receptors, CXCR3; Signal Transduction; T-Lymphocytes; Tumor Burden | 2015 |
Modifying microRNAs--another piece of the melanoma puzzle.
Topics: Adenosine; Animals; Female; Gene Expression Regulation, Neoplastic; Humans; Inosine; Melanocytes; Melanoma; MicroRNAs; RNA Editing; Skin Neoplasms | 2015 |
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation.
Topics: 5'-Nucleotidase; Adenosine; ADP-ribosyl Cyclase 1; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; GPI-Linked Proteins; Humans; Immunologic Memory; Kinetics; Lymphocyte Activation; Melanoma; Membrane Glycoproteins; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Signal Transduction; Skin Neoplasms | 2015 |
Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin.
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Blotting, Western; Caspase 3; Catechin; Cell Line, Tumor; DNA Primers; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Melanoma; Methionine; Methylation; Mice; Microscopy, Confocal; Microscopy, Electron; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Genes, ras; Humans; Male; Melanoma; Mice; Mutation; Phosphorylation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6; Skin Neoplasms; Thionucleosides; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.
Topics: Adenosine; Alprostadil; Cells, Cultured; Cytotoxicity, Immunologic; Dinoprostone; Humans; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Melanoma; Phenethylamines; Receptor Cross-Talk; Receptor, Adenosine A2A; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Skin Neoplasms; T-Lymphocyte Subsets | 2011 |
Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in mice.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; CD8-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunohistochemistry; Immunotherapy, Adoptive; Melanoma; Mice; Mice, Inbred C57BL | 2012 |
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.
Topics: Adenosine; Animals; Apoptosis; Cell Division; CHO Cells; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Humans; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Protein Kinase C; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Tumor Cells, Cultured | 2002 |
A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
Topics: Adenosine; Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Down-Regulation; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasms, Experimental; Protein Transport; Proto-Oncogene Proteins c-myc; Receptor, Adenosine A3; Signal Transduction | 2003 |
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Base Sequence; Cell Division; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A3; RNA, Small Interfering | 2005 |
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.
Topics: Adenosine; Angiopoietin-2; Blotting, Western; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; Oxygen; p38 Mitogen-Activated Protein Kinases; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Time Factors; Transfection; Up-Regulation | 2005 |
A2A adenosine receptor protects tumors from antitumor T cells.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; CD8-Positive T-Lymphocytes; Cell- and Tissue-Based Therapy; Humans; Immunotherapy, Adoptive; Interferon-gamma; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutation; Receptor, Adenosine A2A | 2006 |
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.
Topics: 2-Chloroadenosine; Adenosine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclic AMP-Dependent Protein Kinases; Cytokines; Cytotoxicity, Immunologic; Humans; Melanoma; Receptor, Adenosine A2A; Signal Transduction | 2007 |
Differential effects of NAD, nicotinamide and related compounds upon growth and nucleoside incorporation in human cells.
Topics: Adenosine; Cell Division; Cell Line; DNA Repair; DNA, Neoplasm; Fibroblasts; Humans; Melanoma; NAD; Neoplasms, Experimental; Niacinamide; Nucleosides; RNA, Neoplasm | 1983 |
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.
Topics: Adenosine; Azaserine; Breast Neoplasms; Cell Line; Cell Survival; Humans; Leukemia; Melanoma; Methotrexate; Neoplasms; Pentosyltransferases; Purine-Nucleoside Phosphorylase; Thionucleosides | 1981 |
Solubilization of murine melanoma xylosyltransferase and galactosyltransferase activities and their inactivation by dialdehyde nucleosides.
Topics: Adenosine; Aldehydes; Animals; Cell Fractionation; Cell Line; Cytidine; Galactosyltransferases; Hydrogen-Ion Concentration; Inosine; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Octoxynol; Pentosyltransferases; Polyethylene Glycols; Potassium Chloride; Pyridoxal Phosphate; UDP Xylose-Protein Xylosyltransferase; Uridine | 1982 |
Characterization of adenosine-induced cytostasis in melanoma cells.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Cell Count; Cell Division; Cell Line; Guanosine; Homocysteine; Melanoma; Methylation; Mice; Neoplasms, Experimental; Pyrimidines; RNA, Neoplasm; Uridine | 1980 |
Adenosine and divalent cation effects on S-91 melanoma adenylate cyclase.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cell Membrane; Enzyme Activation; In Vitro Techniques; Manganese; Melanocyte-Stimulating Hormones; Melanoma; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Prostaglandins E; Sodium Fluoride | 1980 |
Toxicity of adenosine analogues against human malaria (Plasmodium falciparum).
Topics: Adenosine; Animals; Antimalarials; Antineoplastic Agents; Deoxyadenosines; Erythrocytes; Humans; Malaria, Falciparum; Melanoma; Plasmodium falciparum; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
Adenosine analogues as antimetabolites against Plasmodium falciparum malaria.
Topics: Adenosine; Animals; Babesia bovis; Chromatography, High Pressure Liquid; Humans; Melanoma; Plasmodium falciparum; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
[Expression of modified nucleoside, 1-methyladenosine in intraocular tumors and the retinas].
Topics: Adenosine; Animals; Choroid Neoplasms; Eye Neoplasms; Humans; Immunohistochemistry; Melanoma; Nucleosides; Rabbits; Retina; Retinoblastoma | 1993 |
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Topics: Adenosine; beta Catenin; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclins; Cytoskeletal Proteins; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Humans; Melanoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Signal Transduction; Trans-Activators; Tumor Cells, Cultured; Ubiquitin; Wnt Proteins; Zebrafish Proteins | 2002 |
Hemolysis induced by 6-N-hydroxylaminopurine riboside, an adenosine analogue.
Topics: Adenosine; Adult; Bilirubin; Blood Cell Count; Breast Neoplasms; Dipyridamole; Erythrocytes; Female; Hemoglobins; Hemolysis; Humans; Hydroxylamines; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Purines; Rectal Neoplasms; Reticulocytes; Time Factors | 1975 |
The toxicity of adenosine analogues against Babesia bovis in vitro.
Topics: Adenosine; Animals; Babesia bovis; Cattle; Melanoma; Tumor Cells, Cultured | 1991 |
Serum has a differential effect on DNA replication in a human melanoma cell line cultured in methionine or 5'-deoxy-5'-methylthioadenosine.
Topics: Adenosine; Blood; Culture Media; Deoxyadenosines; DNA Replication; Humans; Melanoma; Methionine; Thionucleosides; Transferrin; Tumor Cells, Cultured | 1991 |
Exposure of newborn mice to adenosine causes neural crest dysplasia and tumor formation.
Topics: Adenosine; Adrenal Gland Neoplasms; Animals; Animals, Newborn; Bone Neoplasms; Carotid Body Tumor; Digestive System Neoplasms; Melanins; Melanoma; Mice; Mice, Inbred ICR; Muscular Diseases; Neoplasms, Experimental; Nervous System Neoplasms; Neural Crest; Neurofibroma; Peripheral Nervous System Neoplasms; Pheochromocytoma; Pigmentation Disorders; Skin Neoplasms; Tongue Neoplasms | 1989 |